Insulin resistance and type 2 diabetes mellitus: Its relationship with the β3-adrenergic receptor

Archives of Medical Research

Volumn 30, Issue 6, 1999, Pages 459-464

  García Rubi, Ernesto ^a   Calles Escandón, Jorge ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

3 Adrenergic receptor; Diabetes mellitus type 2; G protein coupled receptors; G proteins; Obesity; Trp64Arg 3 adrenergic receptor variant

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; RECEPTOR SUBTYPE;

BROWN ADIPOSE TISSUE; DIABETES MELLITUS; DIABETOGENESIS; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN STRUCTURE; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-3;

EID: 0342614936     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-4409(99)00077-6     Document Type: Review

References (31)

1. Candelore M.R., Deng L., Tota L.M., Kelly L.J., Cascieri M.A., Strader C.D. Pharmacological characterization of a recently described human beta 3-adrenergic receptor mutant. Endocrinology. 137:1996;2638.
2. Strosberg A.D. Structure and function of the beta 3-adrenergic receptor. Annu Rev Pharmacol Toxicol. 37:1997;421.
3. Krief S., Lonnqvist F., Raimbault S.et al. Tissue distribution of beta 3-adrenergic receptor mRNA in man. J Clin Invest. 91:1993;344.
4. Emorine L.J., Feve B., Pairault J.et al. The human beta 3-adrenergic receptor. relationship with atypical receptors Am J Clin Nutr. 55:1992;215S.
5. Nahmias C., Blin N., Elalouf J.M., Mattei M.G., Strosberg A.D., Emorine L.J. Molecular characterization of the mouse beta 3-adrenergic receptor. relationship with the atypical receptor of adipocytes EMBO J. 10:1991;3721.
6. Granneman J.G., Lahners K.N., Chaudhry A. Molecular cloning and expression of the rat beta 3-adrenergic receptor. Mol Pharmacol. 40:1991;895.
7. Feve B., Pietri-Rouxel F., el Hadri K., Drumare M.F., Strosberg A.D. Long term phorbol ester treatment down-regulates the beta 3-adrenergic receptor in 3T3-F442A adipocytes. J Biol Chem. 270:1995;10952.
8. Feve B., Baude B., Krief S., Strosberg A.D., Pairault J., Emorine L.J. Inhibition by dexamethasone of beta 3-adrenergic receptor responsiveness in 3T3-F442A adipocytes. Evidence for a transcriptional mechanism. J Biol Chem. 267:1992;15909.
9. Feve B., Elhadri K., Quignard-Boulange A., Pairault J. Transcriptional down-regulation by insulin of the beta 3-adrenergic receptor expression in 3T3-F442A adipocytes. a mechanism for repressing the cAMP signaling pathway Proc Natl Acad Sci USA. 91:1994;5677.
10. Strosberg A.D. Structure, function, and regulation of the three beta-adrenergic receptors. Obes Res. 3(Suppl 4):1995;501S.
11. Guan X.M., Amend A., Strader C.D. Determination of structural domains for G protein coupling and ligand binding in beta 3-adrenergic receptor. Mol Pharmacol. 48:1995;492.
12. Granneman J.G. Why do adipocytes make the beta 3 adrenergic receptor? Cell Signal. 7:1995;9.
13. Susulic V.S., Frederich R.C., Lawitts J.et al. Targeted disruption of the beta 3-adrenergic receptor gene. J Biol Chem. 270:1995;29483.
14. Umekawa T., Yoshida T., Sakane N., Saito M., Kumamoto K., Kondo M. Anti-obesity and anti-diabetic effects of CL316,243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima fatty rats. induction of uncoupling protein and activation of glucose transporter 4 in white fat Eur J Endocrinol. 136:1997;429.
15. Grujic D., Susulic V.S., Harper M.E.et al. Beta3-adrenergic receptors on white and brown adipocytes mediate beta3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. A study using transgenic and gene knockout mice. J Biol Chem. 272:1997;17686.
16. Hadri K.E., Charon C., Pairault J., Hauguel-De M.S., Quignard B., Feve B. Down-regulation of beta3-adrenergic receptor expression in rat adipose tissue during the fasted/fed transition. evidence for a role of insulin Biochem J. 323:1997;359.
17. Danforth E.J., Himms-Hagen J.H. Obesity and diabetes and the beta-3 adrenergic receptor. (Comment). Eur J Endocrinol. 136:1997;362.
18. de Souza C.J., Hirshman M.F., Horton E.S. CL-316,243, a beta3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats. Diabetes. 46:1997;1257.
19. Walston J., Lowe A., Silver K.et al. The beta3-adrenergic receptor in the obesity and diabetes prone rhesus monkey is very similar to human and contains arginine at codon 64. Gene. 188:1997;207.
20. Walston J., Silver K., Bogardus C.et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. Comments. N Engl J Med. 333:1995;343.
21. Kim-Motoyama H., Yasuda K., Yamaguchi T.et al. A mutation of the beta 3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride. Diabetologia. 40:1997;469.
22. 3-adrenoreceptor gene variant in postmenopausal women. Diabetes. 48:1999;1425.
23. Fujisawa T., Ikegami H., Kawaguchi Y., Ogihara T. Meta-analysis of the association of Trp64Arg polymorphism of beta 3-adrenergic receptor gene with body mass index. J Clin Endocrinol Metab. 83:1998;2441.
24. Sakane N, Yoshida T, Umekawa T, Kogure A, Takakura Y, Kondo M. Effects of Trp64Arg mutation in the beta 3-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients. Diabetes Care 1997;20:1887.
25. Clement K., Ruiz J., Cassard-Doulcier A.M.et al. Additive effect of A-G (-3826) variant of the uncoupling protein gene and the Trp64Arg mutation of the beta 3-adrenergic receptor gene on weight gain in morbid obesity. Int J Obes Relat Metab Disord. 20:1996;1062.
26. Urhammer S.A., Clausen J.O., Hansen T., Pedersen O. Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the beta 3-adrenergic receptor gene. Diabetes. 45:1996;1115.
27. García-Rubi E., Starling R.D., Tchernof A.et al. Trp64Arg variant of the beta3-adrenoceptor and insulin resistance in obese postmenopausal women. J Clin Endocrinol Metab. 83:1998;4002.
28. Janssen J.A., Koper J.W., Stolk R.P.et al. Lack of associations between serum leptin, a polymorphism in the gene for the beta 3-adrenergic receptor and glucose tolerance in the Dutch population. Clin Endocrinol (Oxf). 49:1998;229.
29. Buettner R., Schaffler A., Arndt H.et al. The Trp64Arg polymorphism of the beta 3-adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population-based Caucasian cohort. J Clin Endocrinol Metab. 83:1998;2892.
30. Lepretre F., Vionnet N., Budhan S.et al. Genetic studies of polymorphisms in ten non-insulin-dependent diabetes mellitus candidate genes in Tamil Indians from Pondichery. Diabetes Metab. 24:1998;244.
31. Silver K., Mitchell B.D., Walston J.et al. TRP64ARG beta 3-adrenergic receptor and obesity in Mexican Americans. Hum Genet. 101:1997;306.